M

Mission Bay Capital

4 employees

Mission Bay Capital is a venture capital firm for early-stage investments.

Investor insights

Sectors invested in

Biotechnology29
Health Care21
Therapeutics16
Medical8
Medical Device4
Pharmaceutical3
Consumer Goods3
contact lens technology3
Myeloid Biology2
Translational Research2
Immuno-oncology2
Myeloid Tuning2
Fashion2
Manufacturing2
Life Science2
Biopharma2
Food Processing2
AgTech2
Food and Beverage2
Clinical Trials2

Funding rounds participated in

$13M sweet spot round size

Most of their 36 investments are in rounds between $3.5M and $38M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Life Sciences
Biotechnology
Financial Services
Life Science
Venture Capital
Seed stage investing

Date founded

2009

Investments made

Q

QurAlis raised $88M on March 9, 2023

Investors: Sanofi Ventures, Life Sciences Partners (LSP), MP Healthcare Venture Management Inc, EQT Life Sciences, Mission BioCapital, Inkef and Mission Bay Capital

N

Nitrome Biosciences, Inc. raised $7M on November 2, 2021

Investors: Bristol-Myers Squibb, UK, The Dementia Discovery Fund, Sofinnova Partners and Mission Bay Capital

N

Nobell Foods raised $75M on July 22, 2021

Investors: AgFunder, New Crop Capital, Andreessen Horowitz, Hillhouse Capital Management, Breakthrough Energy Ventures and Mission Bay Capital

S

Symbiome raised $15M on September 14, 2020

Investors: GISEV Family Office, BOLD Capital Partners, True Ventures and Mission Bay Capital

N

Nitrome Biosciences, Inc. raised $38M on April 22, 2020

Investors: Sofinnova Partners, The Dementia Discovery Fund and Mission Bay Capital

G

Glycomine Inc. raised $33M on August 7, 2019

Investors: Chiesi Ventures, Sanderling Ventures, Mission BioCapital, Novo Holdings and Mission Bay Capital

G

GraphWear Technologies Inc. raised $4.2M on April 17, 2018

Investors: Mission BioCapital and Mission Bay Capital

W

Wildtype raised $3.5M on March 30, 2018

Investors: Root Ventures, For Good Ventures, Spark Capital and Mission Bay Capital

V

ViewPoint Therapeutics raised $35M on March 5, 2018

Investors: Lagunita Biosciences, Mission BioCapital and Mission Bay Capital

P

Pionyr Immunotherapeutics raised $62M on December 13, 2017

Investors: OrbiMed Advisors, Vida Ventures, LLC, Osage University Partners (OUP), Sofinnova Ventures, Russia technology fund, QB3 and Mission Bay Capital

FAQ